A critical discovery in cancer study is emerging with the use of nanobodies to restore mutated p53. This vital tumor inhibitor protein is frequently disabled in many kinds of malignancies, causing uncontrolled cell https://johsocial.com/story12666735/vhh-fragments-reactivate-tumor-suppressor-p53-the-potential-hope-for-tumor-management